Seikagaku saw the highest growth of 1.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Seikagaku’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Seikagaku has been focused on protecting inventions in South Korea(KR) with two publications in Q2 2024
The South Korea(KR) Patent Office dominates the patent filings with nearly 100% of filings. The South Korea(KR), United States(US), and Spain(ES) patent Office are among the top ten patent offices where Seikagaku is filings its patents. Among the top granted patent authorities, Seikagaku has 67% of its grants in United States(US) and 33% in Spain(ES).
Roche and Johnson & Johnson could be the strongest competitors for Seikagaku
Patents related to cell & gene therapy lead Seikagaku's portfolio
Seikagaku has the highest number of patents in cell & gene therapy. For cell & gene therapy no patents were filed and 100% of patents were granted in Q2 2024.
Pain related patents lead Seikagaku portfolio
Seikagaku has highest number of patents in pain.
For comprehensive analysis of Seikagaku's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
